Endocrine Reviews

Papers
(The median citation count of Endocrine Reviews is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway358
Papillary Craniopharyngioma: An Integrative and Comprehensive Review301
Insulin/IGF signaling in islet biology and its therapeutic implications284
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome220
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”174
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future163
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases153
DNA Damage and Repair in Thyroid Physiology and Disease147
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies125
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention119
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes118
The Molecular Biology of Midgut Neuroendocrine Neoplasms112
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story99
Effects of Maternal Vitamin D Supplementation on Childhood Health94
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity93
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”91
Calcium-Sensing Receptor Regulation of Gastrointestinal Hormone Secretion90
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?89
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors86
The Biology and Clinical Implications of PCSK781
Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management77
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism75
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status68
Estrogen Receptor Signaling in the Immune System67
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas66
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”65
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia65
Contemporary Biological Insights and Clinical Management of Craniopharyngioma65
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance62
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction61
Steroid receptor coactivators: from basic research to translational opportunities60
Adiponectin and Adiponectin Receptors in Atherosclerosis59
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease57
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling55
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases54
Glycated CD59: a novel biomarker for gestational diabetes53
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood53
Imaging of Pheochromocytomas and Paragangliomas53
The Cortisol Awakening Response: Regulation and Functional Significance52
Epigenetics and disease progression in neuroendocrine neoplasms52
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications50
Molecular and Clinical Spectrum of Primary Hyperparathyroidism50
G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities49
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease49
Medullary Thyroid Cancer: Updates and Challenges48
Protective Factors and the Pathogenesis of Complications in Diabetes47
Endocrine Controls of Skin Aging47
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy44
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency44
Retraction and Replacement of: “Effects of Maternal Vitamin D Supplementation on Childhood Health”44
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management42
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?41
Teprotumumab for the Treatment of Thyroid Eye Disease40
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma39
Epigenetics and childhood obesity: DNA methylation coordinates environment and gene regulation39
Carbohydrate Ingestion on Exercise Metabolism and Physical Performance37
Update on Adipose Tissue and Cancer33
Acromegaly and cardiovascular disease: mechanisms, clinical impact, and evolving management33
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia32
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement29
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision29
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications28
Crosstalk Between the Neuroendocrine System and Bone Homeostasis28
Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies27
Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis27
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens26
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy26
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice25
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome24
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease24
Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications24
Endocrine Dysfunction in Primary Mitochondrial Diseases23
Nuclear Receptors Shape Sepsis Pathophysiology21
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease21
Advances in Adipose Tissue Biology21
The Significance of Hypothalamic Inflammation and Gliosis for the Pathogenesis of Obesity in Humans20
Management of postmenopausal osteoporosis20
0.11756181716919